Investigating serum factors promoting erythrocytic growth of Plasmodium falciparum

Experimental Parasitology

Volumn 109, Issue 1, 2005, Pages 7-15

  Asahi, Hiroko ^a   Kanazawa, Tamotsu ^b   Hirayama, Nakami ^a   Kajihara, Yousei ^c  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c Nihon Trim Co Ltd   (Japan)

Author keywords

ALB; albumin; ANOVA; BSAF; C16:0; C16:1; C18:0; C18:1; C18:2; C18:3; cis,cis 9,12 octadecadienoic acid; cis 9 hexadecenoic acid; cis 9 octadecenoic acid; hexadecanoic acid; multifactorial analysis of variance; NEFA free ALB from bovine; octadecanoic acid

Indexed keywords

ALBUMIN; FATTY ACID; LYSOPHOSPHATIDYLCHOLINE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ERYTHROCYTE; GENE TARGETING; HUMAN; HUMAN CELL; LIPID ANALYSIS; NONHUMAN; PARASITE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; CATTLE; CULTURE MEDIA; ERYTHROCYTES; FATTY ACIDS, NONESTERIFIED; HUMANS; L-LACTATE DEHYDROGENASE; LYSOPHOSPHATIDYLCHOLINES; PLASMODIUM FALCIPARUM; SERUM; SERUM ALBUMIN;

ANIMALIA; BOVINAE; PLASMODIUM FALCIPARUM;

EID: 11444263833     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exppara.2004.10.002     Document Type: Article

References (36)

1. H. Asahi, and T. Kanazawa Continuous cultivation of intraerythrocytic Plasmodium falciparum in a serum-free medium with the use of a growth-promoting factor Parasitology 109 1994 397 401
2. H. Asahi, M. Kawabata, A. Moribayashi, and H. Okumura Cytotoxic factors toward neuroblastoma cells in trypomastigotes of Trypanosoma cruzi Canadian Journal of Microbiology 32 1986 711 718
3. H. Asahi, T. Kanazawa, Y. Kajihara, K. Takahashi, and T. Takahashi Hypoxanthine: a low molecular weight factor essential for growth of erythrocytic Plasmodium falciparum in a serum-free medium Parasitology 113 1996 19 23
4. J. Bain, H. McLauchlan, M. Elliott, and P. Cohen The specificities of protein kinase inhibitors: an update Biochemical Journal 371 2003 199 204
5. B.V. Bassa, D.D. Roh, M.A. Kirschenbaum, and V.S. Kamanna Atherogenic lipoproteins stimulate mesangial cell p42 mitogen-activated protein kinase Journal of the American Society of Nephrology 9 1998 488 496
6. B.V. Bassa, D.D. Roh, N.D. Vaziri, M.A. Kirschenbaum, and V.S. Kamanna Lysophosphatidylcholine activates mesangial cell PKC and MAP kinase by PLCgamma-1 and tyrosine kinase-Ras pathways American Journal of Physiology 277 1999 F328 F337
7. S.L. Cranmer, C. Magowan, J. Liang, R.L. Coppel, and B.M. Cooke An alternative to serum for cultivation of Plasmodium falciparum in vitro Transactions of the Royal Society of Tropical Medicine and Hygiene 91 1997 363 365
8. S.P. Davies, H. Reddy, M. Caivano, and P. Cohen Specificity and mechanism of action of some commonly used protein kinase inhibitors Biochemical Journal 351 2000 95 105
9. A.A. Divo, and J.B. Jensen Studies on serum requirements for the cultivation of Plasmodium falciparum. 2. Medium enrichment Bulletin of the World Health Organization 60 1982 571 575
10. A.R. Dluzewski, and C.R. Garcia Inhibition of invasion and intraerythrocytic development of Plasmodium falciparum by kinase inhibitors Experientia 52 1996 621 623
11. C. Doerig Protein kinases as targets for anti-parasitic chemotherapy Biochimica Biophysica Acta 1697 2004 155 168
12. M.L. Gazarini, and C.R. Garcia Interruption of the blood-stage cycle of the malaria parasite, Plasmodium chabaudi, by protein tyrosine kinase inhibitors Brazilian Journal of Medical and Biological Research 36 2003 1465 1469
13. R. Graeser, P. Kury, R.M. Franklin, and B. Kappes Characterization of a mitogen-activated protein (MAP) kinase from Plasmodium falciparum Molecular Microbiology 23 1997 151 159
14. P. Grellier, D. Rigomier, V. Clavey, J.C. Fruchart, and J. Schrevel Lipid traffic between high density lipoproteins and Plasmodium falciparum-infected red blood cells Journal of Cell Biology 112 1991 267 277
15. K. Hanada, N.M. Palacpac, P.A. Magistrado, K. Kurokawa, G. Rai, D. Sakata, T. Hara, T. Horii, M. Nishijima, and T. Mitamura Plasmodium falciparum phospholipase C hydrolyzing sphingomyelin and lysocholinephospholipids is a possible target for malaria chemotherapy The Journal of Experimental Medicine 195 2002 23 34
16. G.G.J. Holz Lipids and the malarial parasite Bulletin of the World Health Organization 55 1977 237 248
17. J.B. Jensen Some aspects of serum requirements for continuous cultivation of Plasmodium falciparum Bulletin of the World Health Organization 57 Suppl. 1 1979 27 31
18. Q. Jing, S.M. Xin, W.B. Zhang, P. Wang, Y.W. Qin, and G. Pei Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis Circulation Research 87 2000 52 59
19. J.H. Kabarowski, K. Zhu, L.Q. Le, O.N. Witte, and Y. Xu Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A Science 293 2001 702 705
20. B. Kappes, C.D. Doerig, and R. Graeser An overview of Plasmodium protein kinases Parasitology Today 15 1999 449 454
21. T. Kudo, R. Morishita, R. Suzuki, and T. Tachibana A great improvement of fusion efficiency in mouse B cell hybridoma production by use of the new culture medium, GIT Tohoku Journal of Experimental Medicine 153 1987 55 66
22. N. Kume, and M.A.J. Gimbrone Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells Journal of Clinical Investigation 93 1994 907 911
23. M.T. Makler, and D.J. Hinrichs Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia The American Journal of Tropical Medicine and Hygiene 48 1993 205 210
24. M.S. Manku, D.F. Horrobin, Y.S. Huang, and N. Morse Fatty acids in plasma and red cell membranes in normal humans Lipids 18 1983 906 908
25. T. Mitamura, K. Hanada, E.P. Ko-Mitamura, M. Nishijima, and T. Horii Serum factors governing intraerythrocytic development and cell cycle progression of Plasmodium falciparum Parasitology International 49 2000 219 229
26. 2+ and phospholipids The Journal of Biological Chemistry 261 1986 15424 15429
27. H. Ozaki, K. Ishii, H. Arai, N. Kume, and T. Kita Lysophosphatidylcholine activates mitogen-activated protein kinases by a tyrosine kinase-dependent pathway in bovine aortic endothelial cells Atherosclerosis 143 1999 261 266
28. 2+-dependent protein kinases in Plasmodium falciparum Experimental Parasitology 71 1990 39 48
29. A. Sharma Protein tyrosine kinase activity in human malaria parasite Plasmodium falciparum Indian Journal of Experimental Biology 38 2000 1222 1226
30. B.W. Suetterlin, B. Kappes, and R.M. Franklin Localization and stage specific phosphorylation of Plasmodium falciparum phosphoproteins during the intraerythrocytic cycle Molecular and Biochemical Parasitology 46 1991 113 122
31. W. Trager, and J.B. Jenson Cultivation of malarial parasites Nature 273 1978 621 622
32. H.J. Vial, and M.L. Ancelin Malarial lipids I.W. Sherman Malaria: Parasite Biology, Pathogenesis, and Protection 1998 AMS Press Washington, DC, USA 159 175
33. G.E. Ward, H. Fujioka, M. Aikawa, and L.H. Miller Staurosporine inhibits invasion of erythrocytes by malarial merozoites Experimental Parasitology 79 1994 480 487
34. World Health Organization (WHO), 1997. World malaria situation in 1994. Part I. Population at risk. WHO Weekly Epidemiological Record 72, 269-274
35. K. Zhu, L.M. Baudhuin, G. Hong, F.S. Williams, K.L. Cristina, J.H. Kabarowski, O.N. Witte, and Y. Xu Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4 The Journal of Biological Chemistry 276 2001 41325 41335
36. R. Zidovetzki, I.W. Sherman, J. Prudhomme, and J. Crawford Inhibition of Plasmodium falciparum lysophospholipase by anti-malarial drugs and sulphydryl reagents Parasitology 108 1994 249 255